Skip to main content
. 2012 Feb 15;7(2):e31210. doi: 10.1371/journal.pone.0031210

Figure 3. Targeting ESFT cells by chNKG2D-mRNA transfected T cells.

Figure 3

A, Lysis of ESFT cells. The diagram shows the lytic activity of anti-CD3-activated CD8pos and CD4pos T cells transfected with mRNA encoding either chNKG2D or a similar chimeric CMV-gH-specific control receptor (αCMV-gH-CAR) in response to ESFT cells with different ligand expression (stated in brackets). Displayed is the specific lysis of the indicated ESFT cell lines at the indicated E∶T ratio (measured by Eu-release; mean ± S.D. of triplicates). Statistical significance was calculated for the effects of T cells expressing the chNKG2D versus T cells expressing the control receptor where indicated. B and C, Cytokine secretion of chNKG2D-mRNA transfected CD4pos T cells in response to ESFT cells. The diagrams show TNF and FasL secretion by CD4pos T cells transfected with RNA encoding chNKG2D or a CMV-gB-specific control receptor in response to the indicated cell lines or only medium as control (measured by ELISA; mean of duplicates).